Souza-Silva I, Carregari V, Steckelings U, Verano-Braga T
Acta Physiol (Oxf). 2025; 241(2):e14280.
PMID: 39821680
PMC: 11737475.
DOI: 10.1111/apha.14280.
Tang D, Zhao L, Huang S, Li W, He Q, Wang A
Int J Biol Sci. 2024; 20(7):2576-2591.
PMID: 38725862
PMC: 11077360.
DOI: 10.7150/ijbs.94795.
Xu X, Lambert N, Wu G
iScience. 2023; 26(10):107969.
PMID: 37810244
PMC: 10551652.
DOI: 10.1016/j.isci.2023.107969.
Colin M, Delaitre C, Foulquier S, Dupuis F
Molecules. 2023; 28(14).
PMID: 37513355
PMC: 10383525.
DOI: 10.3390/molecules28145481.
Steckelings U, Widdop R, Sturrock E, Lubbe L, Hussain T, Kaschina E
Pharmacol Rev. 2022; 74(4):1051-1135.
PMID: 36180112
PMC: 9553111.
DOI: 10.1124/pharmrev.120.000281.
AT2 activation does not influence brain damage in the early phase after experimental traumatic brain injury in male mice.
Timaru-Kast R, Garcia Bardon A, Luh C, Coronel-Castello S, Songarj P, Griemert E
Sci Rep. 2022; 12(1):14280.
PMID: 35995819
PMC: 9395341.
DOI: 10.1038/s41598-022-18338-x.
Microtubule-Associated Protein ATIP3, an Emerging Target for Personalized Medicine in Breast Cancer.
Haykal M, Rodrigues-Ferreira S, Nahmias C
Cells. 2021; 10(5).
PMID: 34062782
PMC: 8147298.
DOI: 10.3390/cells10051080.
The Angiotensin II Type 2 Receptor, a Target for Protection and Regeneration of the Peripheral Nervous System?.
Danigo A, Rovini A, Bessaguet F, Bouchenaki H, Bernard A, Sturtz F
Pharmaceuticals (Basel). 2021; 14(3).
PMID: 33668331
PMC: 7996246.
DOI: 10.3390/ph14030175.
AT2 receptor interacting protein 1 (ATIP1) mediates COX-2 induction by an AT2 receptor agonist in endothelial cells.
Soda K, Nakada Y, Iwanari H, Hamakubo T
Biochem Biophys Rep. 2020; 24:100850.
PMID: 33381664
PMC: 7767795.
DOI: 10.1016/j.bbrep.2020.100850.
The counter regulatory axis of the renin angiotensin system in the brain and ischaemic stroke: Insight from preclinical stroke studies and therapeutic potential.
McFall A, Nicklin S, Work L
Cell Signal. 2020; 76:109809.
PMID: 33059037
PMC: 7550360.
DOI: 10.1016/j.cellsig.2020.109809.
Recent Research Advances in Renin-Angiotensin-Aldosterone System Receptors.
Azushima K, Morisawa N, Tamura K, Nishiyama A
Curr Hypertens Rep. 2020; 22(3):22.
PMID: 32114685
DOI: 10.1007/s11906-020-1028-6.
Mechanisms of the anterograde trafficking of GPCRs: Regulation of AT1R transport by interacting proteins and motifs.
Zhang M, Wu G
Traffic. 2018; 20(2):110-120.
PMID: 30426616
PMC: 6342637.
DOI: 10.1111/tra.12624.
The Renin-Angiotensin-Aldosterone System as a Therapeutic Target in Late Injury Caused by Ischemia-Reperfusion.
Rodriguez-Lara S, Garcia-Benavides L, Miranda-Diaz A
Int J Endocrinol. 2018; 2018:3614303.
PMID: 29849615
PMC: 5904808.
DOI: 10.1155/2018/3614303.
Dimerization of AT and Mas Receptors in Control of Blood Pressure.
Patel S, Hussain T
Curr Hypertens Rep. 2018; 20(5):41.
PMID: 29717388
PMC: 7479989.
DOI: 10.1007/s11906-018-0845-3.
Mitochondrial tumor suppressor 1 is a target of AT-rich interactive domain 1A and progesterone receptor in the murine uterus.
Chang H, Teasley H, Yoo J, Kim T, Jeong J
Asian-Australas J Anim Sci. 2018; 31(8):1176-1182.
PMID: 29642667
PMC: 6043432.
DOI: 10.5713/ajas.18.0011.
Oncogenic miR-19a and miR-19b co-regulate tumor suppressor MTUS1 to promote cell proliferation and migration in lung cancer.
Gu Y, Liu S, Zhang X, Chen G, Liang H, Yu M
Protein Cell. 2017; 8(6):455-466.
PMID: 28364280
PMC: 5445029.
DOI: 10.1007/s13238-017-0393-7.
Identification of the Mtus1 Splice Variant as a Novel Inhibitory Factor Against Cardiac Hypertrophy.
Ito S, Asakura M, Liao Y, Min K, Takahashi A, Shindo K
J Am Heart Assoc. 2016; 5(7).
PMID: 27385424
PMC: 5015389.
DOI: 10.1161/JAHA.116.003521.
Angiotensin II type 2 receptor-interacting protein 3a suppresses proliferation, migration and invasion in tongue squamous cell carcinoma via the extracellular signal-regulated kinase-Snai2 pathway.
Zhao T, He Q, Liu Z, Ding X, Zhou X, Wang A
Oncol Lett. 2016; 11(1):340-344.
PMID: 26870214
PMC: 4726984.
DOI: 10.3892/ol.2015.3898.
International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].
Karnik S, Unal H, Kemp J, Tirupula K, Eguchi S, Vanderheyden P
Pharmacol Rev. 2015; 67(4):754-819.
PMID: 26315714
PMC: 4630565.
DOI: 10.1124/pr.114.010454.
Association between AT1 and AT2 angiotensin II receptor expression with cell proliferation and angiogenesis in operable breast cancer.
Arrieta O, Villarreal-Garza C, Vizcaino G, Pineda B, Hernandez-Pedro N, Guevara-Salazar P
Tumour Biol. 2015; 36(7):5627-34.
PMID: 25682288
DOI: 10.1007/s13277-015-3235-3.